Faergeman N J, Knudsen J
Institute of Biochemistry, Odense University, DK-5230 Odense, Denmark.
Biochem J. 1997 Apr 1;323 ( Pt 1)(Pt 1):1-12. doi: 10.1042/bj3230001.
The intracellular concentration of free unbound acyl-CoA esters is tightly controlled by feedback inhibition of the acyl-CoA synthetase and is buffered by specific acyl-CoA binding proteins. Excessive increases in the concentration are expected to be prevented by conversion into acylcarnitines or by hydrolysis by acyl-CoA hydrolases. Under normal physiological conditions the free cytosolic concentration of acyl-CoA esters will be in the low nanomolar range, and it is unlikely to exceed 200 nM under the most extreme conditions. The fact that acetyl-CoA carboxylase is active during fatty acid synthesis (Ki for acyl-CoA is 5 nM) indicates strongly that the free cytosolic acyl-CoA concentration is below 5 nM under these conditions. Only a limited number of the reported experiments on the effects of acyl-CoA on cellular functions and enzymes have been carried out at low physiological concentrations in the presence of the appropriate acyl-CoA-buffering binding proteins. Re-evaluation of many of the reported effects is therefore urgently required. However, the observations that the ryanodine-senstitive Ca2+-release channel is regulated by long-chain acyl-CoA esters in the presence of a molar excess of acyl-CoA binding protein and that acetyl-CoA carboxylase, the AMP kinase kinase and the Escherichia coli transcription factor FadR are affected by low nanomolar concentrations of acyl-CoA indicate that long-chain acyl-CoA esters can act as regulatory molecules in vivo. This view is further supported by the observation that fatty acids do not repress expression of acetyl-CoA carboxylase or Delta9-desaturase in yeast deficient in acyl-CoA synthetase.
游离未结合的酰基辅酶A酯的细胞内浓度通过酰基辅酶A合成酶的反馈抑制受到严格控制,并由特定的酰基辅酶A结合蛋白进行缓冲。预计通过转化为酰基肉碱或由酰基辅酶A水解酶水解来防止浓度过度增加。在正常生理条件下,酰基辅酶A酯的游离胞质浓度将处于低纳摩尔范围,在最极端条件下也不太可能超过200 nM。脂肪酸合成过程中乙酰辅酶A羧化酶具有活性(酰基辅酶A的Ki为5 nM)这一事实强烈表明,在这些条件下,游离胞质酰基辅酶A浓度低于5 nM。关于酰基辅酶A对细胞功能和酶影响的报道实验中,只有有限数量是在存在适当酰基辅酶A缓冲结合蛋白的低生理浓度下进行的。因此,迫切需要对许多已报道的效应进行重新评估。然而,在存在摩尔过量的酰基辅酶A结合蛋白的情况下,ryanodine敏感的Ca2+释放通道受长链酰基辅酶A酯调节,以及乙酰辅酶A羧化酶、AMP激酶激酶和大肠杆菌转录因子FadR受低纳摩尔浓度酰基辅酶A影响的观察结果表明,长链酰基辅酶A酯在体内可作为调节分子。酰基辅酶A合成酶缺陷的酵母中脂肪酸不会抑制乙酰辅酶A羧化酶或Δ9-去饱和酶的表达这一观察结果进一步支持了这一观点。